Accessibility Menu
 
Envista logo

Envista

(NYSE) NVST

Current Price$25.96
Market Cap$4.16B
Since IPO (2019)-9%
5 Year-38%
1 Year+47%
1 Month-13%

Envista Financials at a Glance

Market Cap

$4.16B

Revenue (TTM)

$2.72B

Net Income (TTM)

$47.00M

EPS (TTM)

$0.27

P/E Ratio

92.29

Dividend

$0.00

Beta (Volatility)

1.04 (Average)

Price

$25.96

Volume

1,244,062.033

Open

$25.63

Previous Close

$25.37

Daily Range

$25.53 - $26.25

52-Week Range

$14.22 - $30.42

NVST: Motley Fool Moneyball Superscore

61

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Envista

Industry

Healthcare Equipment and Supplies

Employees

12,000

CEO

Paul A. Keel, MBA

Headquarters

Brea, CA 92821-6208, US

NVST Financials

Key Financial Metrics (TTM)

Gross Margin

55%

Operating Margin

8%

Net Income Margin

2%

Return on Equity

2%

Return on Capital

5%

Return on Assets

1%

Earnings Yield

1.08%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$4.16B

Shares Outstanding

163.88M

Volume

1.24M

Short Interest

0.00%

Avg. Volume

2.92M

Financials (TTM)

Gross Profit

$1.50B

Operating Income

$225.70M

EBITDA

$341.70M

Operating Cash Flow

$275.70M

Capital Expenditure

$45.30M

Free Cash Flow

$230.40M

Cash & ST Invst.

$1.21B

Total Debt

$1.71B

Envista Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q4 2025YOY CHG

Revenue

$750.60M

+15.0%

Gross Profit

$413.10M

+10.7%

Gross Margin

55.04%

N/A

Market Cap

$4.16B

N/A

Market Cap/Employee

$338.01K

N/A

Employees

12,300

N/A

Net Income

$32.90M

+2641.7%

EBITDA

$104.90M

+20.0%

Quarterly Fundamentals

Name
Q4 2025YOY CHG

Net Cash

$496.40M

-3.7%

Accounts Receivable

$429.60M

+18.3%

Inventory

$288.10M

+19.5%

Long Term Debt

$1.67B

+19.5%

Short Term Debt

$39.00M

-74.1%

Return on Assets

0.83%

N/A

Return on Invested Capital

4.77%

N/A

Free Cash Flow

$91.70M

-25.9%

Operating Cash Flow

$108.00M

-18.4%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
ALHCAlignment Healthcare, Inc.
$17.80+1.02%
APGEApogee Therapeutics, Inc.
$84.36+0.23%
ICUIICU Medical, Inc.
$125.39-2.91%
DYNDyne Therapeutics, Inc.
$18.20+0.39%

Trending Stocks

Symbol / CompanyPricePrice Chg
CYCNCyclerion Therapeutics
$5.91+2.81%
NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF
$7.44-0.01%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares
$12.72+0.05%
SQQQProShares Trust - ProShares UltraPro Short Qqq
$77.37-0.04%

Questions About NVST

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.